A modern silicone implant optionnow available in the U.S.
- More volume
- More shape
- More cleavage
Yet, many women have safety concerns about using a breast implant in their body to achieve these goals. Commonly, patients express concerns to Dr. Rodriguez about implant rupture or capsular contracture.
Implant rupture with silicone implants does not have the same implications as it once did. “Gummy bear” (highly cohesive) silicone implants contain silicone gel inside them that sticks to itself and tends to hold its form, even when ruptured. This is great because an implant rupture doesn’t mean that an issue with the breast appearance will instantly occur. Still, when an implant ruptures, it can trigger inflammation and increase the likelihood of capsular contracture: a thickening and hardening of the capsule or scar around the breast implant that can, in some cases, result in distortion of the breast implant or discomfort. The risk of silicone breast implant rupture at 10 years after surgery ranges from 16.5-43.9%1,2,3, depending on the manufacturer.
Motiva breast implants have a unique and thoughtful design, aimed at optimizing safety for patients. The risk of implant rupture at 3-6 years after surgery ranges from 0-0.6%4,5,6. The silicone gel inside a Motiva implant has TrueMonobloc technology, meaning that the implant shell sticks to the silicone filling inside the implant. This means it acts as one uniform, strong structure that is resistant to rupture.
With other silicone breast implant manufacturers previously available in the U.S., the rates of developing advanced capsular contracture range from 15.8%-36.9% at 10 years after surgery. In comparison, the Motiva implant has a SmoothSilk surface with a carefully designed implant shell with an average roughness of 4 micrometers. This was specifically designed to optimize biocompatibility of the implant with the human body. The SmoothSilk surface reduces inflammation and foreign body reaction so that the body doesn’t have an overly aggressive response to the Motiva implant shell. The end result is a very thin and soft capsule that forms around the implant in most patients. This means that the capsular contracture rate 3-6 years after surgery is much lower, occurring in 0-0.5% of patients that have not had any prior breast implant surgery4,5,6. For complex revision breast cases, including patients that are being treated for aggressive capsular contracture that has already developed, the capsular contracture recurrence rate after corrective surgery with a Motiva implant is low at 6.7% at 3 years after surgery5.
The Motiva breast implant offers a phenomenal option for patients desiring enhancement of their breast appearance. Motiva breast implants are new to the U.S. but they are not new to the world. In the U.S., we have the benefit of reviewing many years of data from research studies to ensure we are using a safe and reliable product for patients.
After vigorous research studies in the U.S. and abroad, Motiva breast implants were awarded FDA approval for use in the U.S. in October 2024. Ahead of the Motiva breast implant launch in the U.S., Dr. Rodriguez was selected to visit the Motiva breast implant manufacturing facility.
While there, she toured the factory where each Motiva implant is meticulously crafted by hand. Dr. Rodriguez learned directly from the industry-leading breast implant designers and the expert plastic surgeons that have been using Motiva implants with great success for years. Dr. Rodriguez was so impressed by the dedication to excellence and safety at Motiva and is honored to be able to offer Motiva breast implants to her patients. The philosophy at Motiva directly aligns with Dr. Rodriguez’s priorities: providing patients with superb quality and ensuring safety.
If you would like to learn more about Motiva breast implants and understand if they would be a good option for you, please schedule a consultation with Dr. Rodriguez. She is excited to be one of the first plastic surgeons in the Houston area to offer this amazing technology to her patients.
1. Stevens WG, Calobrace MB, Alizadeh A, Zeidler KR, Harrington JL, d’Incelli RC. Ten-year core study data for Sientra’s Food and Drug Administration – approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg. 2018;141(4S):7S-19S.
2. Mentor Worldwide LLC. Patient Decision Checklist: MemoryShape & MemoryGel: https://www.breastimplantsbymentor.com/MENTOR-implant-safety-information. Accessed December 2021.
3. Allergan Sales, LLC. Patient Decision Checklist: https://natrellesurgeon.com/Content/PDF/Augmentation_Consent_Form.pdf. Accessed December 2021.
4. Randquist C, Jaeger M, Stavrou D. Six-Year Evaluation of Motiva Round and Ergonomix SmoothSilk Surface Silicone Breast Implants: A Two-Center, Two-Surgeon Outcome Analysis of 1053 Primary and Secondary Breast Augmentations and Augmentation Mastopexy. Aesthetic Surgery Journal. Vol 43, Issue 3, March 2023, Pages 295-307.
5. Caroline Glicksman, Andrew Wolfe, Patricia McGuire, The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data, Aesthetic Surgery Journal, 2024;, sjae134, https://doi.org/10.1093/asj/sjae134
6. Manuel Chacón Quirós, Manuel Chacón Bolaños, Jeffry James Fassero, Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants, Aesthetic Surgery Journal, Volume 39, Issue 5, May 2019, Pages 495–508, https://doi.org/10.1093/asj/sjy196